Aleplasinin

DB12635InvestigationalSmall molecule

Aleplasinin has been investigated in Alzheimer Disease.

Mechanism: Pharmacologically active on Plasminogen activator inhibitor 1
Curator reviewed
Formula / weight: C₂₈H₂₇NO₃ · 425.528 g/mol (avg)
Code names: PAZ-417

Resolves to

Compound

Structure

InChIKeyHSXLMAFNWCSZGP-UHFFFAOYSA-NSMILESCC1=CC=CC(=C1)C1=CC=C2N(CC3=CC=C(C=C3)C(C)(C)C)C=C(C(=O)C(O)=O)C2=C1

Targets

What you can answer from here — as of June 15, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

4Clinical trialsPhase, status and sponsor resolved per trial

7+ReferencesStructured and connected to the statements they support

Which drugs share a target with Aleplasinin, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.